摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,3R,5R)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane | 905915-70-0

中文名称
——
中文别名
——
英文名称
(2S,3R,5R)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane
英文别名
(2R,3R,5R)-2,3,5-triphenyl-1,4,2lambda5-oxazaphosphinane 2-oxide;(2R,3R,5R)-2,3,5-triphenyl-1,4,2λ5-oxazaphosphinane 2-oxide
(2S,3R,5R)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane化学式
CAS
905915-70-0
化学式
C21H20NO2P
mdl
——
分子量
349.369
InChiKey
ONBULNWCKCSHFY-BPYKYCOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (2S,3R,5R)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane盐酸 作用下, 反应 72.0h, 生成 (2R,3R,5R)-2,3,5-Triphenyl-[1,4,2]oxazaphosphinane 2-oxide; hydrochloride
    参考文献:
    名称:
    Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes
    摘要:
    (2R,3R,5R)-2-芳基-3,5-二苯基-[1,4,2]-氧化膦杂环 6 是C-芳基吗啉醇 3 的模拟物。通过以下三步工艺制备:(i) 甲基次磷酸酯和手性亚胺 10 的对映选择性加成-环化反应;(ii) 钯催化的芳基化反应;(iii) 选择性地在磷中心翻转构型。该过程的对映体过量率高于94%。©2006 Elsevier Ltd. 保留所有权利。
    DOI:
    10.1016/j.tetasy.2006.05.003
  • 作为产物:
    描述:
    D-苯甘氨醇四(三苯基膦)钯 sodium sulfate 、 三乙胺 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 52.0h, 生成 (2S,3R,5R)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane
    参考文献:
    名称:
    Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes
    摘要:
    (2R,3R,5R)-2-芳基-3,5-二苯基-[1,4,2]-氧化膦杂环 6 是C-芳基吗啉醇 3 的模拟物。通过以下三步工艺制备:(i) 甲基次磷酸酯和手性亚胺 10 的对映选择性加成-环化反应;(ii) 钯催化的芳基化反应;(iii) 选择性地在磷中心翻转构型。该过程的对映体过量率高于94%。©2006 Elsevier Ltd. 保留所有权利。
    DOI:
    10.1016/j.tetasy.2006.05.003
点击查看最新优质反应信息

文献信息

  • Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes
    作者:Jean-Noël Volle、David Virieux、Matthieu Starck、Jérôme Monbrun、Ludovic Clarion、Jean-Luc Pirat
    DOI:10.1016/j.tetasy.2006.05.003
    日期:2006.5
    (2R,3R,5R)-2-Aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes 6, analogues of C-arylmorpholinol 3, were prepared with diastereomeric excess higher than 94%, via a three step sequence: (i) diastereoselective addition-cyclization reaction from methyl hypophosphite and a chiral imine 10, (ii) pallado-catalyzed arylation, and then (iii) a selective inversion of configuration at the phosphorus center. (c) 2006 Elsevier Ltd. All rights reserved.
    (2R,3R,5R)-2-芳基-3,5-二苯基-[1,4,2]-氧化膦杂环 6 是C-芳基吗啉醇 3 的模拟物。通过以下三步工艺制备:(i) 甲基次磷酸酯和手性亚胺 10 的对映选择性加成-环化反应;(ii) 钯催化的芳基化反应;(iii) 选择性地在磷中心翻转构型。该过程的对映体过量率高于94%。©2006 Elsevier Ltd. 保留所有权利。
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (2R*,4aS*,8aR*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aR*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2R*,4aS*,8aS*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aS*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (S,S)-2-oxo-2-propionyl-1,3,2-oxaphosphorinane 2-(Dimethylamino)-3-phenyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3,5,5-trimethyl-1,3,2-oxazaphosphorinane cis-2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-phenyl-1,3,2-oxazaphosphorinane 3,3,5,5-tetramethyl-2-oxido-2-oxo-1,4,2-oxaazaphosphorinane 2-(2-chloroethylamino)-3-(1-methyl-2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 4-ethyl-2-hydroxy-2-oxo-tetrahydro-4H-1,4,2-oxazaphosphorine geranyloxyifosfamide 4-methoxy-ifosfamide (2-chloroethyl)-[3-(2-chloroethyl)-2-oxo-4-pentyloxy-2λ5-[1,3,2]oxazaphosphinan-2-yl]amine 3-ethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane Methyl-[3-(3-methyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine 2-Oxo-3-(propan-2-yl)-1,3,2-oxazaphosphinan-2-ium 3-(2-Chloroethyl)-2-(2-chloroethyl)amino-4-hydroxytetrahydro-2H-1,3,2-oxazaphosphorine 3-(2-Chloroethyl)-2-(1-ethyl-2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,5-dimethyl-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,4-dimethyl-, 2-oxide (3-Isopropyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-acetic acid methyl ester cis-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane trans-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane (2S,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2S,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (S)-(2l,6l)-2-(methoxymethyl)-6-methyl-3-(1-methylethyl)-1,3,2-oxazaphosphorinane 2-sulfide (S)-1-((2S,6S)-3-tert-Butyl-6-methyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-3-methyl-hex-5-en-2-one 2-methoxy-1,3,2-oxazaphosphinane 3-(2-Chloroethyl-2-<(2-chloroethyl)-(3-mesyloxytrimethylen)-amino>-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2-chloro-3-[(S)-α-methylbenzyl]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide (S)-(2u,6l)-3-(1,1-Diethylpropyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide 3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one isopropyl-[3-(3-isopropyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine